Document:

yubo_ex108.htm

  EXHIBIT 10.8
  
 CERTAIN PERSONALLY IDENTIFIABLE INFORMATION CONTAINED 
 IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED.
  
 AGREEMENT OF JOINT RESEARCH AND DEVELOPMENT
  
 Party A: Beijing Zhenxigu Medical Research Center (L.P.)
  
 Party B: Yubo International Biotech (Beijing) Limited 
  
 WHEREAS:
  
 Party A is a high-tech R&D center in the biomedicine field, which owns numerous core patent technologies and GMP standard laboratory environment. Its expert team has participated in many national major renewable medical subject and special projects. 
  
 Party B is a company holding shares by Party A. Through friendly consultation, the Parties have reached an agreement to carry out filing application and market cooperation of medical devices on the basis of "repaired liquid dressings (temporary name subject to the approval by FDA)" independently developed by Party A. Now therefore, the Parties agree as follows:
  
 	 1.
	 Both Parties agree that Party A will entrust a full-fledged third party to apply for filing of medical devices, the right to decide on manufacturing of the medical devices and other relevant intellectual property rights shall be owned by Party A. Provided that to the extent permitted by national laws and regulations, the products after the filing, shall bear the words of "Joint Research by Beijing Zhenxigu Medical Research Center, Yubo International Biotech (Beijing) Limited" (the details shall be implemented pursuant to the relevant national regulations) on the package thereof.

	  
	  

	 2.
	 Party A shall be solely responsible for the research and development, the development and application of medical devices of this Project. Party B is responsible for part of the relevant R&D expenses: RMB241,880 (two hundred and forty-one thousand, eight hundred and eighty yuan) shall be deemed as joint research expenses and be paid within 3 working days following the execution of this Agreement.

	  
	  

	 3.
	 As the owner of the manufacturing decision right of filed products and relevant intellectual property rights, Party A hereby authorizes Party B to be the nationwide exclusive distributor of supporting products for Platinum specific atomization inhaler applications, to be responsible for the comprehensive sales and after-sale service of products in the field. Other applications shall not be subject to this restriction.

	  
	  

	 4.
	 After the successful filing and listing, the contribution and cost allocation of the scientific research team shall be taken into full account, and the price shall be re-determined after the actual production costs are accounted for. Party A shall continue to develop other application fields beyond this application, and the Parties shall carry out cooperation in the form of entrustment or joint research and development and enter into agreement on relevant interests in advance.

   
 	 
	
	

	 

     
 	 5.
	 Party A's account information is as follows:

	  
	  

	  
	 Company Name: Beijing Zhenxigu Medical Research Center (L.P.)

	  
	  

	  
	 Unified Social Credit Code: [***************]

	  
	  

	  
	 Opening Bank: China Merchants Bank Beijing West Railway Station Branch

	  
	  

	  
	 Bank Account Number: [***************]

	  
	  

	  
	 Address: Room 301, Building 23, No. 31 Xishiku Street, Xicheng District, Beijing, Tel: 010-56256475

	  
	  

	 6.
	 Party B's invoicing information is as follows:

	  
	  

	  
	 Account Name: Yubo International Biotech (Beijing) Limited 

	  
	  

	  
	 Unified Social Credit Code: [***************]

	  
	  

	  
	 This Agreement is made in quadruplicate. Party A and Party B shall each hold two copies. This Agreement will be effective as long as it is signed and/or sealed. Scanned copies shall have the same legal effect as the originals. 

    
 (The remainder of this page is intentionally left blank)
   
 (This page is the signature page, without text)
    
 Party A: Beijing Zhenxigu Medical Research Center (L.P.) (Seal)
   
 Authorized Representative (Signature)
  
 Party B: Yubo International Biotech (Beijing) Limited (Seal)
  
 Authorized Representative (Signature)
  
 Date of Signature:
  
 Signing time: February 17, 2020yubo_ex109.htm

EXHIBIT 10.9
  
 CERTAIN PERSONALLY IDENTIFIABLE INFORMATION CONTAINED IN 
 THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED.
  
 Cooperation Agreement
  
 Party A: Beijing Zhenxigu Medical Research Center (L.P.)
  
 Party B: Yubo International Biotech (Beijing) Limited 
  
 Party C: Huailai Huayue Hengsheng Medical Device Co., Ltd. 
  
 Through friendly consultations, the Parties hereby agree as follows on [March 1], 2020:
  
 1. All parties concerned agree to carry out strategic cooperation in such aspects as application of scientific research projects, integration of products and technical plans, record-filing of medical devices and preparation for production in response to the novel coronavirus pneumonia epidemic, so as to provide all local health commissions, scientific research institutions and medical units with quality and efficient technical services and operation support for biological medical products, and finally hope to help patients get rid of their suffering as soon as possible. 
  
 2. Party B is the joint R&D company of the "Liquid Dressings" achieved in this Agreement, so Party B will provide part of the R&D funds for the cooperation under this Agreement. 
  
 3. Party C undertakes to provide plant, personnel, technology, products and equipment in relation to the matters under this Agreement. Party A may conduct sample trial production and clinical scientific research in the production workshop of Party C. If construction of the clean workshop is required, both Party A and Party B shall negotiate and make decision on the construction of the clean workshop, while the related costs, personnel and site costs of the detailed rules of cooperation shall be further negotiated and determined. 
  
 4. Party A owns the technical results and intellectual property rights relating to the products researched and developed hereunder. The nationwide total distribution right of " Liquid Dressings" (5ml specifications only) belongs to Party B, unless otherwise agreed by both Party A and Party B. 
  
 5. Party C shall complete the filing of medical devices for liquid dressings of Class 1 ("Medical Device Filing") within [10] business days following the execution of this Agreement. 
  
 	 a)
	 Party A shall assist Party C in the review of the filing materials and contents, especially, the product information and the scope of indications which shall be reflected on the filing certificate of medical devices. The person specially appointed by Party A and the person specially appointed by Party C shall be confirmed in writing.

  
 	 
	
	

	 

  
 	 b)
	 Party C shall inform Party A of progress of the Medical Device Filing Procedures in a timely manner, including without limitation specific information to be submitted.

	  
	  

	 c)
	 The processing fee of medical device filing shall be RMB180,000 (tax inclusive) (RMB in words: one hundred and eighty thousand).

	  
	  

	 d)
	 Within three business days following the execution of this Agreement, Party A shall advance the payment of RMB50,000 to Party C's corporate account. The balance of RMB130,000 shall be paid within [3] business days following Party B and Party C issue the authorization for the product certificate, and Party A receives the scanned copy of the Medical Device Filing Certificate and confirms same. If Party C fails to obtain the Medical Device Filing Certificate within two weeks after the submission of application materials, Party C shall unconditionally refund the advance payment of RMB50,000 to Party A within three weeks upon submission of application materials.

	  
	  

	 e)
	 Party C shall issue the corresponding VAT invoice to Party A within 5 days after the receipt of the advance payment and the last payment respectively.

  
 Party A's invoicing information is as follows:
  
 Company Name: Beijing Zhenxigu Medical Research Center (L.P.)
  
 Unified Social Credit Code: [*************]
  
 Opening Bank: China Merchants Bank Beijing West Railway Station Branch
  
 Bank Account Number: [*************]
  
 Address: Room 301, Building 23, No. 31 Xishiku Street, Xicheng District, Beijing
  
 Telephone: [*************]
  
 Party B's receiving and invoicing information is as follows:
  
 Account Name: Huailai Huayue Hengsheng Medical Device Co., Ltd. 
  
 Tax Number: [*************]
  
 Bank: Shacheng Sub-branch of Zhangjiakou Bank Co., Ltd. 
  
 Account Number: [*************]
  
 Address: Plant No. 11, 301 Jingxi Small Business Start-up Guide Base, Shacheng Economic Development Zone, Huailai County
  
 Telephone: [*************]
  
 	 
	2
	

	 

  
 6. After the successful filing, Party A authorizes Party C to manufacture liquid dressings researched and developed by Party A hereunder ("liquid dressings"). The license term shall expire on [March 1], 2021]. Party C covenants that it has obtained all qualifications required for liquid dressings production, and undertakes to produce and provide liquid dressings based on the request of Party A. Without the prior written consent of Party A, Party C shall not manufacture, sell, authorize or entrust a third party to manufacture, sell liquid dressings or other products researched and developed by Party A. Party A may unilaterally revoke its authorization for Party C to manufacture liquid dressings if Party C breaches the provision of this article and Party C shall pay Party A [RMB500,000] as compensation for breach of contract. 
  
 7. This Agreement is made in triplicate with Party A, Party B and Party C holding one copy respectively. The Agreement shall become effective from the date of signature and seal of the Parties. 
  
 8. Any dispute arising from or in connection with this Agreement shall be settled by the Parties through consultation based on the principle of mutual benefit. If such consultation fails, each Party may file a lawsuit to the people's court of competent jurisdiction in the place where Party A is located. During the course of litigation, this Agreement shall continue to be performed except for the part in dispute in litigation. 
  
 (The remainder of this page is intentionally left blank)
  
 	 
	3
	

	 

  
 As the signature page to the Cooperation Agreement, this page is intentionally left blank. 
  
 Party A: Beijing Zhenxigu Medical Research Center (L.P.) (Seal)
  
 Authorized Representative (Signature)
  
 Date: 2020.5.16
  
  
 Party B: Yubo International Biotech (Beijing) Limited (Seal)
  
 Authorized Representative (Signature)
  
 Date: 2020.5.16
  
  
 Party C: Huailai Huayue Hengsheng Medical Device Co., Ltd. (Seal)
  
 Authorized Representative (Signature)
  
 Date: 2020.5.16
  
 	 
	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}]]